BRVO is an eye condition where one of the smaller veins in the retina becomes blocked. This blockage can restrict blood flow, causing vision problems or even permanent vision loss if not treated timely. Early diagnosis and intervention are crucial for preserving eyesight.
Several factors can contribute to BRVO, including:
Maintaining a healthy lifestyle can lower your chances of developing BRVO.
BRVO is one type of retinal vein occlusion. The other common type is Central Retinal Vein Occlusion (CRVO), which involves the main vein of the retina, rather than just a branch.
While BRVO is more localized, CRVO can lead to more severe vision impairment.
The symptoms of BRVO can vary depending on the extent of the blockage. Common signs include:
If you notice any of these symptoms, especially if they occur suddenly, consult an ophthalmologist like Dr. Suraj Munjal for an immediate check-up.
Diagnosing BRVO involves a comprehensive eye exam. Dr. Suraj Munjal may recommend the following diagnostic tests:
These tests help in confirming the diagnosis and determining the severity of BRVO.
While there’s no cure for BRVO, various treatments can help manage the condition and prevent further vision loss. Dr. Suraj Munjal offers the following treatment options:
India is a popular destination for affordable eye care, and Dr. Suraj Munjal offers world-class BRVO treatments at competitive prices. The cost of BRVO treatment in India varies depending on the treatment plan, but on average:
BRVO can cause vision loss, but with prompt treatment, the risk of permanent blindness can be minimized.
While there’s no sure way to prevent BRVO, managing risk factors such as high blood pressure, diabetes, and cholesterol can significantly reduce the chances of developing it.
Treatment duration depends on the severity of BRVO. Injections may need to be repeated over several months, while laser treatments or surgery may require longer recovery times.
BRVO typically affects one eye, but patients with underlying conditions like diabetes or hypertension are at a higher risk of developing the condition in both eyes.